Evidence map›Paper›PMID 29907982›Full record

ArticleHuman mutation2018

Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disorders.

Eline Overwater, Luisa Marsili, Marieke J H Baars, Annette F Baas, Irma van de Beek, Eelco Dulfer, Johanna M van Hagen, Yvonne Hilhorst-Hofstee, Marlies Kempers, Ingrid P Krapels and 11 more

Open access · hybridAbstract read
In one paragraph

Article in Human mutation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Variable clinical expression of a BelgianFrontiers in genetics · 2023
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 2 countries.

Eline OverwaterDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.ORCID 0000-0002-0993-5035
Luisa MarsiliDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Marieke J H BaarsDepartment of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Annette F BaasDepartment of Medical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.
Irma van de BeekDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Eelco DulferDepartment of Genetics, University Medical Center Groningen, Groningen, the Netherlands.
Johanna M van HagenDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Yvonne Hilhorst-HofsteeDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Marlies KempersDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
Ingrid P KrapelsDepartment of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
Leonie A MenkeDepartment of Pediatrics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Judith M A VerhagenDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-0340-3433
Kak K YeungDepartment of Surgery, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, the Netherlands.
Petra J G ZwijnenburgDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Maarten GroeninkDepartment of Cardiology and Radiology, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands.
Peter van RijnDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Marjan M WeissDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Els VoorhoeveDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
J Peter van TintelenDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Arjan C HouwelingDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Alessandra MaugeriDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Amsterdam UMC Location Vrije Universiteit Amsterdam · NLAmsterdam UMC Location University of Amsterdam · NLErasmus MC · NLLeiden University Medical Center · NLMaastricht University Medical Centre · NLRadboud University Nijmegen · NLUniversity Medical Center Groningen · NLUniversity of Rome Tor Vergata · ITUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Simultaneous analysis of multiple genes using next-generation sequencing (NGS) technology has become widely available. Copy-number variations (CNVs) in disease-associated genes have emerged as a cause for several hereditary disorders. CNVs are, however, not routinely detected using NGS analysis. The aim of this study was to assess the diagnostic yield and the prevalence of CNVs using our panel of Hereditary Thoracic Aortic Disease (H-TAD)-associated genes. Eight hundred ten patients suspected of H-TAD were analyzed by targeted NGS analysis of 21 H-TAD associated genes. In addition, the eXome hidden Markov model (XHMM; an algorithm to identify CNVs in targeted NGS data) was used to detect CNVs in these genes. A pathogenic or likely pathogenic variant was found in 66 of 810 patients (8.1%). Of these 66 pathogenic or likely pathogenic variants, six (9.1%) were CNVs not detectable by routine NGS analysis. These CNVs were four intragenic (multi-)exon deletions in MYLK, TGFB2, SMAD3, and PRKG1, respectively. In addition, a large duplication including NOTCH1 and a large deletion encompassing SCARF2 were detected. As confirmed by additional analyses, both CNVs indicated larger chromosomal abnormalities, which could explain the phenotype in both patients. Given the clinical relevance of the identification of a genetic cause, CNV analysis using a method such as XHMM should be incorporated into the clinical diagnostic care for H-TAD patients.

Indexed as

AdultAorta, ThoracicAortic Aneurysm, ThoracicAortic DiseasesChromosome AberrationsCyclic GMP-Dependent Protein Kinase Type IDNA Copy Number VariationsExomeFemaleGenetic Predisposition to DiseaseGenetic TestingHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedPhenotypeCyclic GMP-Dependent Protein Kinase Type IPRKG1 protein, humanReceptor, Notch1SCARF2 protein, humanScavenger Receptors, Class Fcopy-number variationseXome hidden Markov modelgeneticsthoracic aortic aneurysmthoracic aortic dissection

Identifiers

PMID29907982
PMCPMC6175145
OpenAlexW2808350760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.